Human Amniotic Tissue
Human amniotic tissue allografts processed using proprietary technologies have been shown clinically and scientifically to support soft tissue repair and can release growth factors up to 70-90 X a 5x Concentration PRP. These products are a minimally manipulated human tissue allograft derived from human tissues, and can include the extracellular matrix of the amniotic membrane. It is processed to preserve cytokines, growth factors and scaffolding proteins in amniotic membrane for homologous use.
What is an Allograft?
An allograft is tissue from a human donor that is transplanted from one body to another.
Why Human Amniotic Tissues?
Clinicians have used human amniotic tissues for over a century as a biologic dressing in a broad range of therapeutic applications. They have been generally recognized as versatile wound coverings, with published clinical results cited extensively in the literature. Human amniotic tissues are an abundant source of collagen, as well as other proteins and cytokines. Human amniotic tissues are “immuneprivileged” and therefore rarely cause an immune response in the human body. In addition, this tissue has been shown to have anti-inflammatory, anti-microbial and anti-adhesive properties. The collagens in the amniotic tissue provide a structural tissue matrix for cellular attachment. While providing structural support to cells, the extracellular matrix assists in the migration and proliferation of the patient’s own cells to the site of injury or defect.
The cells inherent in the human placental tissues have been found to be broadly multipotent, capable of differentiating into adipogenic, osteogenic, myogenic, endothelial, neurogenic and hepatic cell lineages. The presence of these multipotent cells naturally present in the tissues may provide ancillary clinical benefits to the patient.